[25] Setthawongsin C,

Techangamsuwan S, Tangkawattana S, Rungsipipat A. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis. The Journal of Veterinary Medical Science. 2016;**78**:1167-1173. DOI: 10.1292/ jvms.15-0710

[26] Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S. Computerized Cytomorphometric and cytomorphological analysis of canine transmissible venereal tumours. Journal of Comparative Pathology. 2018;**163**:18- 22. DOI: 10.1016/j.jcpa.2018.07.003

[27] Amaral AS, Silva SB, Ferreira I, Fonseca LS, Andrade FHE, Gaspar LFJ, et al. Cytomorphological characterization of transmissible venereal tumor. Revista Portuguesa de Ciencias Veterinarians. 2007;**102**:253-260

[28] Paranzini CS, Santanna MC, Santis GW, Martins MIM. Prevalence of different cytomorphological types of transmissible venereal tumours and the association with prognosis in dogs treated with vincristine sulphateretrospective study. Semina: Cien Agrar. 2015;**36**:3795-3800. DOI: 10.5433/ 1679-0359.2015v36n6p3795

[29] Silva SB, Sforcin JM, Amaral AS, Gaspar LFJ, Rocha NS. Propolis effect in vitro on canine transmissible venereal tumor cells. Revista Portuguesa de Ciencias Veterinarians. 2007;**102**:261-265

[30] Gaspar LFJ, Ferreira I, Colodel MM, Brandão CVS, Rocha NS. Spontaneous canine transmissible venereal tumor: Cell morphology and influence on P-glycoprotein expression. Turkish Journal of Veterinary and Animal Science. 2010;**34**:447-454

[31] Liao KW, Lin ZY, Pao HN, Kam SY, Wang FI, Chu RM. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. Journal of Veterinary Diagnostic Investigation. 2003;**15**(5):399-406. DOI: 10.1177/ 104063870301500501

[32] Duzanski AP, Flórez LMM, Fêo HB, Romagnoli GG, Kaneno R, Rocha NS. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT? Research in Veterinary Science. 2022;**145**:193-204. DOI: 10.1016/j.rvsc.2022.02.020

[33] Vilensky J, Koudinova NV, Harmelin A, Scherz A, Salomon Y. Vascular-targeted photodynamic therapy (VTP) of a canine-transmissible venereal tumour in a murine model with

Pd-bacteriopheophorbide (WST09). Veterinary and Comparative Oncology. 2005;**3**(4):182-193. DOI: 10.1111/j. 1476-5810.2005.00078.x

[34] Sudjaidee P, Theewasutrakul P, Techarungchaikul S, Ponglowhapan S, Chatdarong K. Treatment of canine transmissible venereal tumor using vincristine sulfate combined with L-asparaginase in clinical vincristineresistant cases: A case report. Thai Journal of Veterinary Medicine. 2012;**42**:117-122

[35] Belmont AS, Nicolini CA. Cell versus nuclear morphometry of serumstimulated fibroblasts: Nuclear changes precede cell changes. Journal of Cell Science. 1982;**58**:201-209. DOI: 10.1242/ jcs.58.1.201

[36] Prvulović I, Skelin IK, Sustercić D, Razumović JJ, Manojlović S. Morphometry of tumor cells in different grades and types of breast cancer. Collegium Antropologicum. 2010;**34**:99-103

[37] Hsiao YW, Liao KW, Hung SW, Chu RM. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Veterinary Immunology and Immunopathology. 2002;**87**:19-27. DOI: 10.1016/ s0165-2427(02)00026-0

[38] Hill DL, Yang TJ, Wachtel A. Canine transmissible venereal sarcoma: Tumor cell and infiltrating leukocyte ultrastructure at different growth stage. Veterinary Pathology. 1984;**21**:39-45. DOI: 10.1177/030098588402100107

[39] Marcos R, Santos M, Marrinhas C, Rocha E. Cutanous transmissible venereal tumor without genital involvement in a prepubertal female dog. Veterinary Clinical Pathology. 2006;**35**:106-109. DOI: 10.1111/j.1939-165X.2006.tb00097.x

*Canine Transmissible Venereal Tumor: An Infectious Neoplasia in Dogs DOI: http://dx.doi.org/10.5772/intechopen.106150*

[40] Frampton D, Schwenzer H, Marino G, Butcher LM, Pollara G, Vizi JK, et al. Molecular signatures of regression of the canine transmissible venereal tumor. Cancer Cell. 2018;**33**(4):620-633.e6. DOI: 10.1016/j. ccell.2018.03.003

[41] Pérez J, Day MJ, Mozos E. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth. Veterinary Immunology and Immunopathology. 1998;**64**(2):133-147. DOI: 10.1016/ s0165-2427(98)00131-7

[42] Berry CM. Understanding interferon subtype therapy for viral infections: Harnessing the power of the innate immune system. Cytokine & Growth Factor Reviews. 2016;**31**:83-90. DOI: 10.1016/j.cytogfr.2016.08.001

[43] Hsiao YW, Liao KW, Chung TF, Liu CH, Hsu CD, Chu RM. Interactions of host IL-6 and IFN-gamma and cancerderived TGF-beta1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunology, Immunotherapy. 2008;**57**(7):1091-1104. DOI: 10.1007/s00262-007-0446-5

[44] Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S. In vitro effect of recombinant feline interferon-Ω (rFeIFN-Ω) on the primary CanineTransmissible venereal tumor culture. Frontiers in Veterinary Science. 2019;**6**:104. DOI: 10.3389/ fvets.2019.00104

[45] Kanca H, Tez G, Bal K, Ozen D, Alcigir E, Vural SA. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour. Veterinary Medical Science. 2018;**4**(4):364-372. DOI: 10.1002/ vms3.119

Section 3
